Nitromethaqualone
Nitromethaqualone[1] is an analogue of methaqualone that has similar sedative and hypnotic properties.[2] It is significantly more potent (10×) compared to the parent compound; the typical dose is approximately 25 mg.
![]() | |
Clinical data | |
---|---|
ATC code |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C16H13N3O4 |
Molar mass | 311.297 g·mol−1 |
3D model (JSmol) | |
|
References
- US patent 3162634, Klosa J (Berlin, Germany), "2-Methyl-3-(2'-methyl-3'-chlorphenyl)-quinazolone-(4)", issued 1964-12-22
- Szirmai A (November 1963). "[Pharmacological and Therapeutic Studies with a New Quinazolone Derivative, Nitromethaqualone]". Therapeutische Umschau. Revue Therapeutique (in German). 20: 542–6. PMID 14101319.
Alcohols |
|
---|---|
Barbiturates |
|
Benzodiazepines |
|
Carbamates |
|
Flavonoids | |
Imidazoles |
|
Kava constituents |
|
Monoureides |
|
Neuroactive steroids |
|
Nonbenzodiazepines |
|
Phenols | |
Piperidinediones |
|
Pyrazolopyridines |
|
Quinazolinones |
|
Volatiles/gases |
|
Others/unsorted |
|
See also: Receptor/signaling modulators • GABA receptor modulators • GABA metabolism/transport modulators |
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.